Abstract
Systemic therapy against gynaecological cancers is now firmly established. The majority of patients with gynaecological cancer will have disease which is inappropriate for cure with local therapy such as surgery or radiotherapy. Chemotherapy will increase the cure rate in a number of patients and offer useful palliation to many others. This article is concerned with stressing the importance of chemotherapy in certain situations and also identifying some of the dilemmas that still confront the clinician in the management of gynaecological cancer with systemic therapy.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
